[Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin III]. 1984

M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan
January 1993, Nihon rinsho. Japanese journal of clinical medicine,
M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan
January 1977, Folia haematologica (Leipzig, Germany : 1928),
M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan
December 1995, Thrombosis research,
M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan
April 2003, Anales de medicina interna (Madrid, Spain : 1984),
M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan
January 2003, The American journal of the medical sciences,
M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan
July 1985, European journal of pediatrics,
M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan
February 1997, Ugeskrift for laeger,
M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan
October 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
M Gouault-Heilmann, and G Contant, and G Pochmalicki, and F Jan
May 1989, Circulatory shock,
Copied contents to your clipboard!